Cyprus to give vaccine booster doses to population aged 65 and above

The fourth wave of COVID-19 caused by the virus’s Delta variant, which prompted a record 1,152 daily cases in mid-July, has been contained by health officials in Cyprus.

“Important steps have been taken to stop the Delta variant and to curb the reluctance of those to get vaccinated,” Hadjipantelas said. He said Cyprus had the second-lowest coronavirus mortality rate among European Union countries after Finland, with 507 deaths and 114,131 cases since the outbreak began in March 2020.

A new computational technique developed at the University of Michigan may anticipate how individual patients are likely to respond, shedding light on why particular vaccines may affect people differently.

It could lead to new vaccine design concepts in the future that take an individual’s specific features into account, potentially enabling HIV vaccinations and more effective flu protection.

“Different people vary in the amount and type of antibodies they produce,” said Kelly Arnold, a U-M assistant professor of biomedical engineering and a corresponding author on a new study published in Cell Reports Medicine. “Depending on their genetics, they also have different protein sequences in their antibodies and immune cell receptors that cause them to bind differently.

“That situation is difficult for researchers to understand based on experiments. And that’s why this computational model has been so valuable. We can make personalized models for different people that take all of these different factors into account.”